Bacterial Overgrowth of the Small Intestine - SIBO [3hr] - (G)
Breath
Days
Indications
- Digestive discomfort: abdominal pain, bloating or excessive gas after meals.
- Altered bowel habits: constipation, diarrhoea or alternating patterns.
- Carbohydrate intolerance: difficulty tolerating sweet or starchy foods, fibre or certain supplements.
- Unexplained nutritional concerns: anaemia, weight loss or signs of malabsorption or maldigestion.
- Chronic fatigue: tiredness potentially considered in relation to digestive factors.
- IBS-type symptoms: fluctuating digestive patterns that resemble irritable bowel presentations.
- Hypochlorhydria: suspected low stomach acid associated with upper digestive symptoms, including in clients with long-term use of acid-blocking drugs.
- Osteoporosis or low bone density: under review where malabsorption is suspected.
- Unexplained abdominal symptoms: discomfort with no clear cause, especially when linked with bloating.
Overview
The Bacterial Overgrowth of the Small Intestine - SIBO [3hr] - (G) test involves collecting breath samples at timed intervals after consuming lactulose. This process measures levels of hydrogen and methane gases, which result from microbial fermentation of lactulose within the small intestine. Tracking these gas patterns over time provides insights into fermentation activity that occurs in this part of the digestive tract.
This test offers valuable information for those interested in understanding digestive function and gut balance. It can highlight variations in gas production that may relate to overall digestive comfort, nutrient absorption, and bowel habits. The structured sampling period of three hours allows observation of how fermentation gases develop and change during this timeframe, assisting users in exploring potential influences on their digestive environment.
Interpreting the SIBO test results typically involves considering them alongside lifestyle factors such as diet, digestive patterns, and general wellbeing observations. This contextual approach supports individuals in gaining a broader perspective on their digestive health and can contribute to informed discussions around personal care strategies and wellness optimisation.
Bacterial Overgrowth of the Small Intestine - SIBO [3hr] - (G) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Bacterial Overgrowth of the Small Intestine - SIBO [3hr] - (G) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.
Downloads
Sample Report
Research
Research
• Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. 2010;16(24).
• Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to Rifaximin for the treatment of small intestinal bacterial Overgrowth. Global Advances in Health and Medicine. 2014;3(3):16–24.
• Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial Overgrowth. 2007;3(2).
• Erdogan A, Rao SSC. Small Intestinal Fungal Overgrowth. Current Gastroenterology Reports. 2015;17(4).
• Fasano A. Leaky gut and autoimmune diseases. Clinical reviews in allergy & immunology. 2011;42(1):71–8.
• Gabbard S, Lacy B, Levine G, Crowell M. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Digestive diseases and sciences. 2013;59(3):638–44.
• Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. European Journal of Gastroenterology & Hepatology. 2014;26(7):753-760.
• Ghoshal UC. How to Interpret Hydrogen Breath Tests. Journal of Neurogastroenterology and Motility. 2011;17(3):312-317.
• Hauge T, Persson J, Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion. 2009;58(6):591–595.
• Lauritano E, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. The American journal of gastroenterology. 2008;103(8):2031–5.
• Levitt MD. Volume and Composition of Human Intestinal Gas Determined by Means of an Intestinal Washout Technic. New England Journal of Medicine. 1971;284(25):1394-1398.
• Lloyd-Still JD, Shwachman H. Duodenal microflora. The American Journal of Digestive Diseases. 1975;20(8):708-715.
• Methodology and Indications of H2-Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference. Alimentary Pharmacology & Therapeutics. 2009;29:1-49.
• Newberry C, Tierney A, Pickett-Blakely O. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender. BioMed Research International. 2016;2016:1-5.
• Rana S, Sharma S, Kaur J, Sinha S, Singh K. Comparison of Lactulose and Glucose Breath Test for Diagnosis of Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome. Digestion. 2012;85(3):243-247.
• Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scandinavian Journal of Gastroenterology. 2008;43(9):1030-1037.
• Roland B, Ciarleglio M, Clarke J, et al. Small intestinal transit time is delayed in small intestinal bacterial Overgrowth. Journal of clinical gastroenterology. 2014;49(7):571–6.
• Saad RJ, Chey WD. Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy. Clinical Gastroenterology and Hepatology. 2014;12(12):1964-1972.
All‑in‑one functional medicine platform for education, testing, and patient care.
Nordic Laboratories ApS
Simply Nature Ltd
Stonegate East Sussex TN5 7DU,
United Kingdom